• TwosubcutaneousdosingoptionsofAJOVYareavailableto injectionsitereactions.(6.1) administertherecommendeddosage: o 225mgmonthly,or ToreportSUSPECTEDADVERSEREACTIONS,contactTeva o 675mgevery3months(quarterly)(2.1) Pharmaceuticalsat1-orFDAat1-800-FDA-1088 ...
Ajovy and Aimovig are both calcitonin gene-related peptide (CGRP) inhibitors used for migraine prevention in adults. The dosing, side effects, effectiveness and costs of these medicines can vary. As demonstrated in studies, these agents can reduce the number of migraine headache days you experienc...
in some countries, in a pre-filled pen. Two dosing options are available: 225 mg once monthly administered as one subcutaneous injection (monthly dosing), or 675 mg every three months